A clinical trial to study the effect of two drugs oxytocin and carbetocin in management of third stage of labour in vaginal deliveries

Oxytocin vs carbetocin in management of third stage of labour in vaginal deliveries - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066832

Enrollment

170

Registered

2024-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Oxytocin Carbetocin: Oxytocin 10 units Carbetocin 100 mcg Intervention2: Oxytocin vs carbetocin in management of third stage of labour in vaginal deliveries: In trial group,carbetocin

Eligibility

Inclusion criteria

Inclusion criteria: All women undergoing vaginal delivery

Exclusion criteria

Exclusion criteria: Women who undergo caesarean section Women with proven hypersensitivity to oxytocin and carbetocin

Design outcomes

Primary

Measure	Time frame
Postpartum haemorrhage more than 500 ml blood lossTimepoint: Postpartum haemorrhage more than 500 ml blood loss	—

Secondary

Measure	Time frame
Need for blood Transfusion and fall in hemoglobin levelsTimepoint: Hemoglobin fall more than 1 gm/dl	—

Countries

India

Contacts

Public ContactNikhil D Kamarthi

Rajendra institute of medical sciences

meenamehta196272@gmail.com9431129618

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026